Point72 Asset Management
RYTM icon

Point72 Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

Point72 Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$73.6M Buy
846,801
+417,381
+97% +$40.6M 0.09% 242
2025
Q4 		$46M Buy
+429,420
New +$45.6M 0.05% 444
2025
Q3 		– Sell
-170,832
Closed -$10.8M – 2633
2025
Q2 		$10.8M Buy
170,832
+106,990
+168% +$6.55M 0.02% 705
2025
Q1 		$3.38M Buy
+63,842
New +$3.54M 0.01% 1081
2023
Q4 		– Sell
-4,146
Closed -$95K – 2729
2023
Q3 		$95K Buy
+4,146
New +$92.8K ﹤0.01% 1978
2023
Q2 		– Sell
-11,955
Closed -$213K – 2706
2023
Q1 		$213K Buy
+11,955
New +$300K ﹤0.01% 1464
2018
Q2 		– Sell
-180,000
Closed -$3.58M – 1155
2018
Q1 		$3.58M Buy
180,000
+100,000
+125% +$2.66M 0.02% 644
2017
Q4 		$2.33M Buy
+80,000
New +$2.12M 0.01% 711

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Point72 Asset Management's RYTM Position: Q1 2026 in Review

Point72 Asset Management increased its Rhythm Pharmaceuticals (RYTM) stake by 97% in Q1 2026, buying an estimated $40.6M and bringing the position to 846,801 shares worth $73.6M. The position accounts for 0.09% of the portfolio, ranked #242.

Point72 Asset Management first reported a position in RYTM in Q4 2017 and has held it in 8 quarters since. 285 funds tracked by Wall St. Rank hold RYTM as of Q1 2026.

  • Point72 Asset Management held 846,801 shares of Rhythm Pharmaceuticals worth $73.6M as of Q1 2026.
  • Point72 Asset Management bought 417,381 Rhythm Pharmaceuticals shares in Q1 2026, an estimated $40.6M.
  • Rhythm Pharmaceuticals made up 0.09% of Point72 Asset Management's portfolio in Q1 2026, its #242 holding.
  • Point72 Asset Management first reported a position in Rhythm Pharmaceuticals in Q4 2017 and has held it in 8 quarters since.
  • 285 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.